title: New therapies for tuber-less sclerosis: white matter matters?
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Ess
authors.forename: E Steve
authors.initials: ES
authors.lastname: Roach
mesh_terms: D003337:Corpus Callosum / Q000187:drug effects*; D056324:Diffusion Tensor Imaging; D000068338:Everolimus; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D009413:Nerve Fibers, Myelinated / Q000187:drug effects*; D020123:Sirolimus / Q000031:analogs & derivatives* / Q000494:pharmacology; D014402:Tuberous Sclerosis / Q000503:physiopathology*
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus